Spatial distribution, sources and potential health risks of organochlorine pesticides (OCPs), including hexachlorocyclohexane (HCH) and dichlorodiphenyltrichloroethane (DDT), in surface soils (n = 544) collected from a typical alluvial plain of the Yangtze River Delta region, China, were elucidated. Concentrations of ΣHCH and ΣDDT in soils ranged from less than the limit of detection (
Download full-text PDF
Source
http://dx.doi.org/10.1007/s10653-013-9554-7 DOI Listing Publication Analysis
Top Keywords
Similar Publications
A robust transfer learning approach for high-dimensional linear regression to support integration of multi-source gene expression data.
PLoS Comput Biol
January 2025
Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
Transfer learning aims to integrate useful information from multi-source datasets to improve the learning performance of target data. This can be effectively applied in genomics when we learn the gene associations in a target tissue, and data from other tissues can be integrated. However, heavy-tail distribution and outliers are common in genomics data, which poses challenges to the effectiveness of current transfer learning approaches.
View Article and Find Full Text PDFQuantitative LC-MS/MS Analysis of Endogenous Isomeric Metabolites Biliverdin IX Alpha, Beta, and Delta in Cell Culture Supernatant, Cell Pellet, and Lung Tissue.
J Proteome Res
January 2025
School of Pharmacy, Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland 21201, United States.
() utilizes heme as an iron source from the host during infection. Biliverdin beta and delta (BVIXβ and BVIXδ) are generated by HemO, specific to , while biliverdin alpha is generated from the bacterial BphO system and by mammalian heme oxygenases. Here, we have developed and characterized a quantitative LC-MS/MS assay for the separation of three endogenous isomers, BVIXα, BVIXβ, and BVIXδ.
View Article and Find Full Text PDFFirst report of a major management target species, chironomid Paratanytarsus grimmii (Diptera: Chironomidae) larvae, in drinking water treatment plants (DWTPs) in South Korea.
PLoS One
January 2025
Department of Ocean Integrated Science, Chonnam National University, Yeosu, Korea.
Ensuring the supply of safe and high-quality drinking water can be compromised by the presence of chironomid larvae in drinking water treatment plants (DWTPs), which may contaminate municipal water systems through freshwater resources. Chironomids are dominant species known for their resilience to a broad range of extreme aquatic environments. This study aimed to identify the morphological characteristics and obtain genetic information of the chironomid Paratanytarsus grimmii found in the water intake source and freshwater resource of DWTPs in Korea, highlighting the potential possibility of a parthenogenetic chironomid outbreak within DWTP networks.
View Article and Find Full Text PDFQuantifying spectral information about source separation in multisource odour plumes.
PLoS One
January 2025
Sensory Circuits and Neurotechnology Laboratory, The Francis Crick Institute, London, United Kingdom.
Odours released by objects in natural environments can contain information about their spatial locations. In particular, the correlation of odour concentration timeseries produced by two spatially separated sources contains information about the distance between the sources. For example, mice are able to distinguish correlated and anti-correlated odour fluctuations at frequencies up to 40 Hz, while insect olfactory receptor neurons can resolve fluctuations exceeding 100 Hz.
View Article and Find Full Text PDFDoctors as Device Manufacturers? Regulation of Clinician-Generated Innovation in the ICU.
Crit Care Med
December 2024
Division of Neurocritical Care, Massachusetts General Hospital, Boston, MA.
Critical care physicians are rich sources of innovation, developing new diagnostic, prognostic, and treatment tools they deploy in clinical practice, including novel software-based tools. Many of these tools are validated and promise to actively help patients, but physicians may be unlikely to distribute, implement, or share them with other centers noncommercially because of unsettled ethical, regulatory, or medicolegal concerns. This Viewpoint explores the potential barriers and risks critical care physicians face in disseminating device-related innovations for noncommercial purposes and proposes a framework for risk-based evaluation to foster clear pathways to safeguard equitable patient access and responsible implementation of clinician-generated technological innovations in critical care.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!